Table 2.
Prognostic Factors | HR | 95% CI | p-Value |
---|---|---|---|
Age (per 1-year increase) | 1.04 | 1.00–1.08 | 0.04 * |
Sex (female vs. male) | 1.22 | 0.55–2.72 | 0.62 |
Histology (adenocarcinoma vs. non-adenocarcinoma) |
0.38 | 0.18–0.83 | 0.02 * |
GPA score (high vs. low) | 0.21 | 0.09–0.45 | <0.001 * |
Integrin β3 (per 1-ng/mL increase) | 1.25 | 1.04–1.49 | 0.02 * |
Integrin β6 (per 1-ng/mL increase) | 0.90 | 0.68–1.18 | 0.44 |
Abbreviations: HR, hazard ratio; CI, confidence interval; vs., versus; GPA, graded prognostic assessment. Asterisk denotes significance.